34563004|PMC8482202
{'Chemical', 'Disease', 'Species', 'Mutation', 'Gene'}
Headache, a common prodromal symptom of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, can also be a manifestation of cerebral venous thrombosis (CVT), secondary to COVID-19. Development of CVT, secondary to SARS-CoV-2 infection, is being increasingly recognized. This report has highlighted the need for an increased awareness of coagulopathy and thrombotic events, including cerebral venous thrombosis, in patients infected with SARS-CoV-2.